Cargando…
Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios
BACKGROUND: Bioresorbable vascular scaffolds (BVS) have become an emerging tool to treat coronary artery disease. However, the current use of BVS is still widely restricted to stable patients and non-complex lesions. In real-world practice patients are far more complex than those with simple type A...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315475/ https://www.ncbi.nlm.nih.gov/pubmed/25173111 http://dx.doi.org/10.1007/s00392-014-0757-4 |
_version_ | 1782355480382799872 |
---|---|
author | Jaguszewski, Milosz Ghadri, Jelena-Rima Zipponi, Manuel Bataiosu, Dana Roxana Diekmann, Johanna Geyer, Verena Neumann, Catharina Anna Huber, Mia Aurelia Hagl, Christian Erne, Paul Lüscher, Thomas F. Templin, Christian |
author_facet | Jaguszewski, Milosz Ghadri, Jelena-Rima Zipponi, Manuel Bataiosu, Dana Roxana Diekmann, Johanna Geyer, Verena Neumann, Catharina Anna Huber, Mia Aurelia Hagl, Christian Erne, Paul Lüscher, Thomas F. Templin, Christian |
author_sort | Jaguszewski, Milosz |
collection | PubMed |
description | BACKGROUND: Bioresorbable vascular scaffolds (BVS) have become an emerging tool to treat coronary artery disease. However, the current use of BVS is still widely restricted to stable patients and non-complex lesions. In real-world practice patients are far more complex than those with simple type A lesions and the extended use of BVS to complex lesions and high-risk patients needs to be evaluated. Therefore, we sought to investigate the feasibility and performance of BVS in a broad spectrum of patients. METHODS: 106 patients underwent in total 193 BVS implantations. We assessed the device-related (cardiac death, target vessel myocardial infarction, ischemia-driven target lesion revascularization) and patient-related (all-cause death, any reinfarction and any revascularization) composite outcomes. RESULTS: 90 % of patients (n = 95) had at least one of the following characteristics: >65 years (35 %), ACS (42 %), tortuous vessels (13 %), calcified (17 %) or thrombotic lesions (12 %), lesions defined as AHA type B2/C (42 %), bifurcations (16 %), chronic total occlusions (9 %) or restenosis (14 %). There was no evidence of significant edge dissection, huge thrombus load or incidence of scaffold dislodgement or scaffold disruption in optical coherence tomography pullbacks. Out of 10,157 struts evaluated within 1,117 cross-sections, 302 were classified as malapposed (2.9 %). During a mean follow-up of 147 ± 119 days the rate of device-related events was 2.0 %, whereas patient-related composite events occurred in 6.1 %. CONCLUSIONS: Our results strongly suggest that BVS implantation is feasible in a wide spectrum of patients and complex anatomy of coronary lesions. Long-term outcome of BVS should be further investigated in unrestricted settings in randomized controlled trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00392-014-0757-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4315475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-43154752015-02-05 Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios Jaguszewski, Milosz Ghadri, Jelena-Rima Zipponi, Manuel Bataiosu, Dana Roxana Diekmann, Johanna Geyer, Verena Neumann, Catharina Anna Huber, Mia Aurelia Hagl, Christian Erne, Paul Lüscher, Thomas F. Templin, Christian Clin Res Cardiol Original Paper BACKGROUND: Bioresorbable vascular scaffolds (BVS) have become an emerging tool to treat coronary artery disease. However, the current use of BVS is still widely restricted to stable patients and non-complex lesions. In real-world practice patients are far more complex than those with simple type A lesions and the extended use of BVS to complex lesions and high-risk patients needs to be evaluated. Therefore, we sought to investigate the feasibility and performance of BVS in a broad spectrum of patients. METHODS: 106 patients underwent in total 193 BVS implantations. We assessed the device-related (cardiac death, target vessel myocardial infarction, ischemia-driven target lesion revascularization) and patient-related (all-cause death, any reinfarction and any revascularization) composite outcomes. RESULTS: 90 % of patients (n = 95) had at least one of the following characteristics: >65 years (35 %), ACS (42 %), tortuous vessels (13 %), calcified (17 %) or thrombotic lesions (12 %), lesions defined as AHA type B2/C (42 %), bifurcations (16 %), chronic total occlusions (9 %) or restenosis (14 %). There was no evidence of significant edge dissection, huge thrombus load or incidence of scaffold dislodgement or scaffold disruption in optical coherence tomography pullbacks. Out of 10,157 struts evaluated within 1,117 cross-sections, 302 were classified as malapposed (2.9 %). During a mean follow-up of 147 ± 119 days the rate of device-related events was 2.0 %, whereas patient-related composite events occurred in 6.1 %. CONCLUSIONS: Our results strongly suggest that BVS implantation is feasible in a wide spectrum of patients and complex anatomy of coronary lesions. Long-term outcome of BVS should be further investigated in unrestricted settings in randomized controlled trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00392-014-0757-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2014-08-31 2015 /pmc/articles/PMC4315475/ /pubmed/25173111 http://dx.doi.org/10.1007/s00392-014-0757-4 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Paper Jaguszewski, Milosz Ghadri, Jelena-Rima Zipponi, Manuel Bataiosu, Dana Roxana Diekmann, Johanna Geyer, Verena Neumann, Catharina Anna Huber, Mia Aurelia Hagl, Christian Erne, Paul Lüscher, Thomas F. Templin, Christian Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
title | Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
title_full | Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
title_fullStr | Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
title_full_unstemmed | Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
title_short | Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
title_sort | feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315475/ https://www.ncbi.nlm.nih.gov/pubmed/25173111 http://dx.doi.org/10.1007/s00392-014-0757-4 |
work_keys_str_mv | AT jaguszewskimilosz feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT ghadrijelenarima feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT zipponimanuel feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT bataiosudanaroxana feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT diekmannjohanna feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT geyerverena feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT neumanncatharinaanna feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT hubermiaaurelia feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT haglchristian feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT ernepaul feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT luscherthomasf feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios AT templinchristian feasibilityofsecondgenerationbioresorbablevascularscaffoldimplantationincomplexanatomicalandclinicalscenarios |